Miller SL

References (2)

Title : The M1 Muscarinic Receptor Antagonist VU0255035 Delays the Development of Status Epilepticus after Organophosphate Exposure and Prevents Hyperexcitability in the Basolateral Amygdala - Miller_2017_J.Pharmacol.Exp.Ther_360_23
Author(s) : Miller SL , Aroniadou-Anderjaska V , Pidoplichko VI , Figueiredo TH , Apland JP , Krishnan JK , Braga MF
Ref : Journal of Pharmacology & Experimental Therapeutics , 360 :23 , 2017
Abstract : Miller_2017_J.Pharmacol.Exp.Ther_360_23
ESTHER : Miller_2017_J.Pharmacol.Exp.Ther_360_23
PubMedSearch : Miller_2017_J.Pharmacol.Exp.Ther_360_23
PubMedID: 27799295

Title : A rat model of nerve agent exposure applicable to the pediatric population: The anticonvulsant efficacies of atropine and GluK1 antagonists - Miller_2015_Toxicol.Appl.Pharmacol_284_204
Author(s) : Miller SL , Aroniadou-Anderjaska V , Figueiredo TH , Prager EM , Almeida-Suhett CP , Apland JP , Braga MF
Ref : Toxicol Appl Pharmacol , 284 :204 , 2015
Abstract : Miller_2015_Toxicol.Appl.Pharmacol_284_204
ESTHER : Miller_2015_Toxicol.Appl.Pharmacol_284_204
PubMedSearch : Miller_2015_Toxicol.Appl.Pharmacol_284_204
PubMedID: 25689173